DUBLIN–(BUSINESS WIRE)–Report “Global Active Pharmaceutical Ingredients Market 2021-2028” has been added to from ResearchAndMarkets.com offer.
Global Active Pharmaceutical Ingredients Market to Reach $334 Billion by 2028, Growing 6.9% YoY Over 2021-2028, Driven by Growing Adoption of Biologics in Disease Management, increasing regulatory approvals, expiring major drug patents, the growing trend of outsourcing and the rise of geriatrics. population.
In-depth analyzes and assessments are generated from premium primary and secondary information sources with input from industry professionals across the value chain. The report is based on studies for 2018-2021 and provides forecasts from 2022 to 2028 with 2021 as the base year.
The global market trend and outlook is forecasted in an optimistic, balanced and conservative view considering COVID-19. The balanced (most likely) projection is used to quantify the global Active Pharmaceutical Ingredients market across all aspects of classification from the perspective of synthesis, manufacturing process, therapeutic application, drug type and of the region.
In-depth qualitative analyzes include the identification and investigation of the following aspects:
-
Market structure
-
Growth engines
-
Constraints and challenges
-
Emerging Product Trends and Market Opportunities
-
Porter’s Five Forces
On the basis of Synthesis, the global market is segmented into the following sub-markets with annual revenue (USD Billion) for 2018-2028 included in each section.
Synthetic API
-
Brand synthetic API
-
Generic Synthetic API
Biotechnology API by drug type:
-
Monoclonal antibodies
-
Recombinant proteins
-
Vaccines
-
Other Biotech APIs
Biotechnology API by clientele:
-
Innovative biological API
-
Generic Biosimilar API
Biotechnology API by Expression Technology:
-
expression mammal
-
Microbial expression
-
yeast expression
-
insect expression
-
Other Expression Technologies
HPAPI
-
Branded HPAPIs
-
Generic HPAPI
On the basis of manufacturing process, the global market is segmented into the following sub-markets with annual revenue (USD Billion) for 2018-2028 included in each section.
Captive Manufacturing
-
Branded Captive API
-
Generic Captive API
Market manufacture by type of drug:
-
Branded Merchant API
-
Generic Merchant API
Commercial manufacture by drug synthesis:
-
Merchant Synthetic API
-
Merchant Biotech API
By therapeutic application, the global market is segmented into the following sub-markets with annual revenue (USD Billion) for 2018-2028 included in each section.
-
Infectious diseases
-
Oncology
-
Ophthalmology
-
Cardiovascular disorders
-
Central nervous system
-
Lung disorders
-
Orthopedics
-
Other Apps
By Drug Type, the global market is segmented into the following sub-markets with annual revenue (USD Billion) for 2018-2028 included in each section.
-
Prescription brand drugs
-
Generic prescription drugs
-
Over-the-counter medications
Selected key players:
-
AbbVie Inc.
-
Astrazeneca
-
Aurobindo Pharma Ltd.
-
BASF
-
Bayer AG
-
Boehringer Ingelheim
-
Catalent Inc.
-
Dr. Reddy’s Laboratories
-
F. Hoffmann-La Roche
-
GlaxoSmithKline plc
-
Lonza Group
-
Lupine Limited
-
Merck & Co., Inc.
-
Mylan AG
-
Novartis International SA
-
Pfizer Inc.
-
Sanofi
-
Sun Pharmaceutical Industries Ltd.
-
Teva Pharmaceutical Industries Ltd.
-
Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/r/v6gc2v
